Tonix Pharmaceuticals (NASDAQ: TNXP)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.600 | -1.600 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Tonix Pharmaceuticals (NASDAQ: TNXP) through any online brokerage.
Other companies in Tonix Pharmaceuticals’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP), Synaptogenix (NASDAQ:SNPX) and Celyad Oncology (NASDAQ:CYAD).
The latest price target for Tonix Pharmaceuticals (NASDAQ: TNXP) was reported by Noble Capital Markets on Monday, April 18, 2022. The analyst firm set a price target for 0.60 expecting TNXP to fall to within 12 months (a possible -67.91% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $1.87 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Tonix Pharmaceuticals.
Tonix Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Tonix Pharmaceuticals.
Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.